Sfoglia per AUTORE
SAGGIA C
Collezione AOU Novara

  

Items : 6

Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT. in European journal of radiology / Eur J Radiol. 2021 Aug;141:109821. doi: 10.1016/j.ejrad.2021.109821. Epub 2021 Jun 10.

2021
AOU Novara

Degenhardt T; Wuerstlein R; Harbeck N; Rossi V; Saggia C; Dib B; Sacchetti GM; Alberini JL; Brain E; Monti M; Nanni O; Rocca A; Matteucci F; Fiz F; Siri G; Piccardo A; Bottoni G; DeCensi A; Rollandi GA; Gennari A;

COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 Nov 2;13:17588359211053416. doi: 10.1177/17588359211053416. eCollection 202

2021
AO Alessandria
AOU Novara

Salazar R; Chopra N; Romeo M; Viansone A; Fotia V; Krengli M; Delany MB; Ruiz I; Newsom-Davis T; Porzio G; Del Mastro L; Bertuzzi A; Ciruelos EM; Pla H; Prat A; Strina C; Marin M; Van Hemelrijck M; Mukherjee U; Galazi M; Colomba-Blameble E; Chiudinelli L; Saggia C; Matas M; Aguilar Company J; Sharkey R; Loizidou A; Wuerstlein R; Berardi R; et alii...

A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study. in Clinical breast cancer / Clin Breast Cancer. 2019 Apr;19(2):137-145.e4. doi: 10.1016/j.clbc.2018.11.009. Epub 2018 Nov 24.

2019
ASL Biella
AOU Novara

Toffoli G; Innocenti F; Saggia C; Bonura S; Clerico M; Riccardi F; Baldelli AM; Amoroso V; Basso U; Medici M; Foghini L; Fabbri MA; Benedetti G; Rocca A; Serra P; Vattemi E; Cretella E; Sandri P; Pellegrino A; Gianni L; Spagnoletti I; Merkabaoui G; Bari M; Collovà E; Meo R; Saracchini S; Gasparini G; Sartori D; Cinausero M; et alii...

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial-a multicenter retrospective study of eribulin in real life. in SpringerPlus / Springerplus. 2016 Jan 21;5:59. doi: 10.1186/s40064-016-1700-0. eCollection 2016.

2016
ASL Torino 4
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Biella
ASL Vercelli
ASL Alessandria
AOU Novara

Merlano MC; Polimeni MA; Oletti MV; Lucio F; Airoldi M; De Conciliis E; La Verde N; Vandone AM; Donadio M; Giacobino A; Saggia C; Montemurro F; Garrone O;

The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer. in PloS one / PLoS One. 2015 Sep 4;10(9):e0136731. doi: 10.1371/journal.pone.0136731. eCollection 2015.

2015
ASL Cuneo 1
AO Cuneo
AOU Novara

Mentuccia L; Laudadio L; Zoboli A; Marchetti F; Bogina G; Lunardi G; Boni L; Gamucci T; Evangelisti L; Barni S; Saracchini S; Amaducci L; Santini D; Fabi A; Garrone O; Frassoldati A; Cavanna L; Saggia C; Bria E; Cretella E; Vici P; Spazzapan S; Iezzi L; De Simone V; Duranti S; Cavazzini MG; Turazza M; Gubiotti M; Foglietta J; et alii...

FISH in triple-negative breast cancer: a possible strategy for the future? in Future oncology (London, England) / Future Oncol. 2015;11(7):1023-6. doi: 10.2217/fon.15.25.

2015
AOU Novara

Rigon E; Saggia C; Rossi V; Genestroni S; Gaudino E; Campisi P; Veggiani C; Boldorini RL; Alabiso O;